Assessing the economic and health impact of clinical trials prospectively (i.e., before conducting the trials) could optimise research prioritisation and funding decisions by identifying the trials with the potential to maximise the returns on research investment
ACTA’s ‘A pilot study to prospectively estimate the health and economic return on research investment’ focuses on the real-world application of research prioritisation by a Clinical Trial Network.
This insightful study was a shared project between the Research Prioritisation and Impact and Implementation of Clinical Trial Networks Reference Groups, and was prepared for ACTA by A/Prof Haitham Tuffaha and Prof Stephen Birch.
We sincerely thank everyone involved in preparing this important work and we hope you find the study useful in your applications.
Resource Documents
A pilot study to prospectively estimate the health and economic return on research investment
